Paul Marks to Head Search Committee For National Cancer Institute Director

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 3
Volume 4
Issue 3

WASHINGTON--HHS Secretary Donna Shalala has appointed Paul Marks, president, Memorial Sloan-Kettering Cancer Institute, to chair the search committee for a director of the National Cancer Institute, to replace Dr. Samuel Broder, who now plans to leave in March instead of April as originally announced.

WASHINGTON--HHS Secretary Donna Shalala has appointed Paul Marks,president, Memorial Sloan-Kettering Cancer Institute, to chairthe search committee for a director of the National Cancer Institute,to replace Dr. Samuel Broder, who now plans to leave in Marchinstead of April as originally announced.

The 14-member committee (twice as large as the one convened tofind a replacement for Vincent DeVita) is expected to make itsrecommendations to the White House by March 15.

Other committee members are Frances Visco, JD, National BreastCancer Coalition; Karen Antman, Columbia University; FernandoCabanillas, M.D. Anderson; Anthony Fauci, National Institute ofAllergy and Infectious Diseases; Harold Freeman, chairman, President'sCancer Panel; Maxine Singer, Carnegie Institute; and Eli Glatsteinand Joseph Goldstein, University of Texas Southwestern MedicalCenter.

Also, Kenneth Olden, National Institute of Environmental HealthSciences; Shirley Tilghman, Howard Hughes Medical Institute; ChristopherWalsh, Dana-Farber; Samuel Wells, Washington University; and CharlesWilson, University of California, San Francisco.

Related Videos
Video 8 - "Closing Thoughts on the Future of NSCLC"
Video 7 - "Molecular Testing: Key Takeaways on Next Generation Sequencing in NSCLC "
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
Samer A. Al'Hadidi, MD, with Rahul Gosain, MD, and Rohit Gosain, MD
video 8 - "Treatment Landscape for NSCLC With EGFR Exon 20 Insertion Mutations"
Video 7 - "Second-Line Treatment of Patients With EGFR-Mutated NSCLC"
A panel of 5 experts on liver cancer